Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

Similar documents
Building a new model of sustainable chemistry. Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO

Solvay expands its specialty polymers offerings with Ryton PPS acquisition

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Driving Profitable Growth

Nutrition Chris Goppelsroeder President & CEO DSM Nutritional Products ROYAL DSM HEALTH NUTRITION MATERIALS

Championing patients every step of the way

BALCHEM CORPORATION. Q Investor Relations Presentation

Dentivera Milling Discs. Powering the Digital Revolution. Supported by Solvay. Make METAL-FREE Possible with Ultaire AKP. Dental Lab Advantages

Solvay India April 2017

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address

Partnering for Growth

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Global EHS Leaders Survey 2017: EHS Consulting Brands

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

Nestlé Investor Seminar 2008

Consumer Health Care V5.0_2013

Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions

Harm de Wildt MD TNI

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

The Wright Grou. the history of

The acquisition of Fortitech

Innovator Case Studies: Oncology Networks

Launch of a new binders : Leveraging innovation to an economic advantage.

Solvay. in short Solvay SA Rue de Ransbeek, Brussels Belgium T:

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Clustered Nutrition. - Dr. R. B. Smarta

ph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria

FRANKFURT SITE TOUR 2017

FIRSTQUARTER2018 RESULTSPRESENTATION

The dental market. Facts, trends and dynamics.

Health for Humanity 2020 Goals 2

Country Coverage. Company Coverage

Elekta Synergy Digital accelerator for advanced IGRT

Boston Scientific is advancing...

Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022

Putting ALK on the right growth trajectory

Elekta Infinity. Digital accelerator for advanced treatments. Redefining treatment precision, speed and control

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Let s share our talents

Because you care about CONSUMERS HEALTH

To be the partner of choice Straumann

Brain research supported by the European Union

biomérieux - First-Half 2009 Business Review

Global Dental Implant and Prosthetics Market (By Implant Type, By Prosthetics Type, By Material, By Stage): Opportunities and Forecasts ( )

GE Healthcare 9900 Innovation Drive Wauwatosa, WI U.S.A.

Solvay. Brigitte Laurent Senior Vice President Group Innovation Champion. SOLVAY S.A. Proprietary

MarketsandMarkets. Publisher Sample

Industry Partners. Information and Benefits

Ultrasonic Flowmeter Study Overview

Solvay in India January, 2014

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Cochlear Limited 2017 Annual General Meeting Chairman s Address

Nordea investor meeting. June 18 th, 2018 Kristian Villumsen, EVP Chronic Care

DuPont Nutrition & Health Craig Binetti, President

A world leader in allergy immunotherapy

Elekta Innovation and Growth. ESTRO 2012 Capital Markets Presentation

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008.

Company presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018

STRATEGIC PLAN

SMART Communities Need A SMART Workforce Partners in SMART Education and Workforce Development & Training

Cochlear Limited 2018 Annual General Meeting Chairman s Address

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

ASKING MORE 2015 COMPLEMENTARY ANNUAL REPORT - SUSTAINABLE DEVELOPMENT INFORMATIONS

Second Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1

A world leader in allergy immunotherapy

Vitamin Supplements XYMOGEN EP

SUPPORTING EMPLOYEES WITH CANCER: THE CANCER CARE HUDDLE. March 26, 2018

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

Genomic Health. Kim Popovits, Chairman, CEO and President

STRATEGIC PLAN

Imaging Systems. Gene Saragnese EVP and GM Imaging Systems

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.

OPPORTUNITIES FOR HHS & DOD COLLABORATION FOR MEDICAL COUNTERMEASURES

Carbon Digital Dentures: the 5-Stage, Step-by-Step Instruction Guide

Global Deaf/Hearing Aid Market ( Edition) July 2017

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

DP-50 Mindray DP-50 Digital Ultrasonic Diagnostic Imaging System Outstanding image performance in a compact design

NEWSCLIPPINGS. Publication: Cincinnati Business Section: News

OLEASING From CAPEX to OPEX. The flexibility of an investment-free solution

Livongo Drives 1.4x ROI in Year 1 for Dean Foods

GBU data & processes

Photocure ASA Executing the Strategy

Chronic Care Coloplast Meet the Management London 2017 Kristian Villumsen, EVP Chronic Care Edmond Veome, SVP Chronic Care North America

Attracting Talent & Driving Growth in Wisconsin

Global Coverage. Regional Coverage. Country Coverage Company Coverage

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

COIL PROCESSING SOLUTIONS

Rising to the Challenge of Satisfying Unmet Medical Needs. Back-of-the-eye. Main Back-of-the-Eye Diseases. Uveitis. Behcet s disease.

Forward Looking Information

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

2018 INFUSE CALL FOR INNOVATION

Myriad Genetics Corporate Presentation 06/13/2018

11. December 2017 Marianne Birkeland Kjær

Member-centered cancer care In Georgia

View Report Details. Global Coronary Stent Market

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

Transcription:

Solvay Media Kit

Table of Contents 1. About Solvay 3 1.1. Solvay at a Glance 4 1.2. Group Portfolio 5 2. Transforming Solvay 6 2.1. Solvay s Portfolio Upgrade 7 3. Organizing for the Future 9 3.1. Why does Solvay need to adapt its organization? 9 3.2. Simplification to Refocus Activities 10 4. Upgraded innovation capabilities in an open and collaborative work environment 11 5. Impact on employment and employees 12 2

1. About Solvay Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry which addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used to enhance efficiency and sustainability in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction. Solvay s lightweighting materials promote cleaner mobility, its formulations optimize the use of resources, and its performance chemicals improve air and water quality. 3

1.1. Solvay at a Glance (based on FY 2017 Figures) 24,500 employees 124 industrial sites 21% 17% Industrial applications Consumer goods & Healthcare 8% Building & Construction 61 countries 10.1 billion of net sales 21 major R&I centers 2,230 billion of underlying EBITDA 6% Electrical & Electronics 11% Agro, Feed & Food 14% Resources & Environment 23% Automotive & Aeronautics 2017 underlying results Distribution of net sales 2017 underlying results 4

1.2. Group Portfolio Advanced Materials Providing solutions for sustainable mobility, lightweighting, CO 2 and energy efficiency Advanced Formulations Customized specialty formulations in surface chemistry and liquid behavior, maximizing yield & efficiency, minimizing eco impact Performance Chemicals Leading positions in chemical intermediates through scale & technology, developing innovative application & industrial innovation for optimized costs 5

2. Transforming Solvay Since the beginning of the 21st century, the pace of change in the world has accelerated dramatically as new materials and technologies transform the way society operates. For Solvay, that change has culminated in a profound transformation of the business. More GLOBAL More DIVERSIFIED More SPECIALTY More SUSTAINABLE Net Sales 2017 10.1 billion ~33% in each main region >50% in GDP+ markets >70% specialty products ~49% sustainable solutions Europe Asia & ROW Latin America North America Automotive & aerospace Electrical & electronics Resources & environment Agro, feed & food Consumer goods & healthcare Building & construction Industrial applications Advanced materials Advanced Formulations Performance Chemicals Sustainable solutions Neutral impact Challenged applications (according to SPM methodology) 6

2.1. Solvay s Portfolio Upgrade Thanks to the acquisition of new companies and complementary technologies, and the divestment of others, Solvay s profile has evolved into global multi-specialty chemicals. About 50 of these transactions in five years have seen the Group s focus shift from traditional, large volume, and cyclical products towards advanced materials and specialty chemicals tailored to the needs of specific markets and customers. ACQUISITIONS Cytec Energain LT-CF plant Enhancing customized solution offerings Rhodia Chemlogics Pipeline DIVESTMENTS Ryton Eco Services Benvic PCC Inovyn Indupa Form. Resins Vinythai Acetow 2011 2012 2013 2014 2015 2016 2017 XL compounds Dakarto Benvic Polyamide* Refrigerants Phosphorous Reducing cyclical & low-growth businesses exposure * Divestment in progress, expected to be finalized by the end of 2018 7

Solvay s portfolio transformation has brought the Group business in cutting-edge international markets including aerospace where our composite materials replace metals on key parts like wings, and smart devices where our materials are used to protect the camera or speakers. The new and existing customers Solvay supplies in these markets have evolved their ways of working and now require: Rapid Technological Innovation Top-tier Talent Personalized Service Faster Response Times Customers expect top-class, personalized service, and the latest technological advances delivered as quickly as possible so they can outperform their competition. In the fast-paced world of smart devices for example, products need to be developed within tight timeframes (sometimes within just a few months) to prove concepts and support the rapid production schedule of popular models. Solvay wants to grow with these customers. By adapting its way of working, Solvay can devote more time and energy to meeting their needs. For the Group as a whole, this will mean even more opportunities to generate long-term growth and contribute to a more sustainable world. 2.1. Solvay s Portfolio Upgrade 8

2023 2022 2021 2020 2019 2018 2017 2017 3. Organizing for the Future To complete its profound transformation into an advanced materials and specialty chemicals company, Solvay first presented plans to align its organization worldwide more than a year ago. Today the Group has announced the detail of this new step: a project to simplify the way of working throughout the organisation and to optimize and concentrate some of Solvay s European research and innovation (R&I) activities. 3.1. Why does Solvay need to adapt its organization? Between 2012 and 2018, the Group dramatically changed and upgraded its portfolio with high-growth, high-value businesses to create new opportunities in the global marketplace. But Solvay s organization has not yet fully adapted to its new scope, extended client base, or the changed global marketplace. 2 /3 2016 of New Activities (not in the Group perimeter 6 years ago) New Customers 9

Faster The changes Solvay wants to implement are designed to bridge that gap and turn the Group into a simpler, more agile, and outward-looking organization. It will also open up the way Solvay works and deliver the innovative technologies that customers and society are asking for. 3.2. Simplification to become more customer-focused Simpler More than 500 employees from throughout the Group have worked over the past year to identify unnecessary complexity and co-design a transformation project which will make Solvay a faster, simpler, and more customer-centric business. Creating simpler ways of working includes reducing the number of process and administrative tasks and better use of digital technologies. Refocusing activities will impact the structure of the organization, roles, and responsibilities. But it will also free-up employees to spend more time with clients, understand their needs as early as possible in their projects, and work side-by-side with them to co-innovate solutions. Customer-focus 10

4. Upgraded innovation capabilities in an open and collaborative work environment To organize for the future and align the business to its new scope, Solvay is planning to upgrade part of its European innovation capabilities and to consolidate its business and support activities which are scattered across four locations in Belgium and in France today. The profound transformation of Solvay s business portfolio has significantly reduced the Group s activities in those two countries. Solvay plans to relocate the R&I, business and support activities performed in Aubervilliers and in Paris, principally to Lyon and, to a lesser extent, Brussels. A small representation office will remain in Paris. Concentrating the bulk of its French R&I in Lyon, already Solvay s largest R&I site, will involve creating a worldclass Innovation and Technology Center. Here, some 750 researchers will benefit from the region s international innovation and scientific eco-system and strong chemical industry presence. R&I activities in Brussels will be expanded into advanced materials science as part of an overall project to revamp the Group s headquarters. Creating a more collaborative work environment will also draw partners to the Solvay Campus and foster open innovation. There will be a four-year transition period during which the Group will concentrate R&I activities into these centers. 11

5. Impact on employment and employees This project will have consequences for employment. The simplification of the organization will lead to approximately 600 net redundancies, mainly in functional activities, including 160 in France, 90 in Portugal and 80 in Brazil and 20 in Belgium. Natural turnover, voluntary leave, and a priority to reposition collaborators in redundant jobs within the Group, should help mitigate the impact. The concentration of R&I activities in Lyon and Brussels will see about 500 employees transferred from the Paris area over the next four years. These employees can rely on comprehensive support from the Group to manage a smooth transition also for their families, including schooling, housing and job support for spouses. Solvay is fully aware that such an ambitious project will constitute a challenge for many involved. In line with its social values, Solvay is committed to limiting job losses as much as possible and to support employees in this transformation journey. The Group today launched the relevant information and consultation procedures with employee representatives. The procedures are expected to be completed end June, allowing effective implementation of the project over the next four years. Project Launch May 2018 Completion 2021-2022 12